First-Line Treatment for Hypertension with Blood Pressure 160/90 mmHg
For a patient with hypertension and a blood pressure reading of 160/90 mmHg, immediate initiation of both lifestyle interventions and antihypertensive drug therapy is recommended, with specific medication choices based on patient demographics. 1
Initial Assessment and Classification
- This blood pressure reading (160/90 mmHg) classifies as Grade 2 Hypertension, requiring prompt treatment 1
- Confirmation of the elevated reading should be done using a validated device with appropriate cuff size 2
- Target: Reduce BP by at least 20/10 mmHg initially, with ultimate goal of <130/80 mmHg 1
Immediate Treatment Approach
Pharmacological Therapy
For Non-Black Patients:
- Start with low-dose ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB) 1
- Lisinopril (ACEI) is an appropriate first-line agent that has been shown to lower blood pressure and reduce cardiovascular risk 3
- Consider increasing to full dose if target BP is not achieved 1
- Add a thiazide/thiazide-like diuretic if BP remains uncontrolled 1
For Black Patients:
- Start with low-dose ARB plus dihydropyridine calcium channel blocker (DHP-CCB) or DHP-CCB plus thiazide/thiazide-like diuretic 1
- Amlodipine (DHP-CCB) is an effective option as it produces vasodilation resulting in reduction of blood pressure 4
- Increase to full dose if needed 1
Lifestyle Interventions (to be started concurrently)
- Weight loss if overweight or obese 1
- DASH-style eating pattern with reduced sodium (<2,300 mg/day) and increased potassium intake 1, 5
- Regular physical activity (30-60 minutes, 4-7 days per week) 5, 6
- Moderation of alcohol intake (≤2 drinks/day for men, ≤1 drink/day for women) 1
- Smoking cessation if applicable 5
Follow-up and Monitoring
- Schedule follow-up within 2-4 weeks to assess response to therapy 2
- Aim to achieve target BP within 3 months 1
- For patients on ACEI, ARB, or diuretic, monitor serum creatinine/eGFR and potassium levels at least annually 1
- Consider home BP monitoring to track progress and improve adherence 2
Important Considerations and Pitfalls
- Single-pill combinations may improve adherence and should be considered 1, 7
- Avoid combining ACE inhibitors with ARBs as this combination increases adverse effects without additional benefit 1
- Most patients will require multiple medications to achieve target BP 8, 7
- For patients with albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g), an ACEI or ARB should be included in the regimen 1
- If BP remains uncontrolled on a three-drug regimen, consider adding spironolactone 1
- Be vigilant for potential side effects such as hyperkalemia with ACEI/ARB therapy, especially in patients with reduced kidney function 1